Bio-Imaging Technologies Financial Statements
Bio-Imaging Technologies Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Bio-Imaging Technologies Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 47.9 | 40.5 | 30.5 |
| Gross Profit ($ mil.) | 16.3 | 12.4 | 5.4 |
| Operating Income ($ mil.) | 3.2 | 1.1 | (4.3) |
| Total Net Income ($ mil.) | 2.3 | 1.0 | (2.5) |
| Diluted EPS (Net Income) | 0.18 | 0.08 | (0.23) |
Bio-Imaging Technologies Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 19.3 | 14.2 | 12.7 |
| Gross Profit ($ mil.) | 6.7 | 4.8 | 4.6 |
| Operating Income ($ mil.) | 1.6 | 1.1 | 1.1 |
| Total Net Income ($ mil.) | 1.1 | 0.8 | 0.8 |
| Diluted EPS (Net Income) | 0.07 | 0.06 | 0.06 |
Bio-Imaging Technologies Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.83 | 1.39 | 1.54 |
| Price/Earnings Ratio | 28.85 | 21.95 | 15.76 |
| Price/Book Ratio | 2.54 | 2.89 | 1.49 |
| Price/Cash Flow Ratio | 9.16 | 14.28 | 9.63 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Bio-Imaging Technologies Financial Ratios
Bio-Imaging Technologies Competitive Intelligence
| DATATRAK International | Pharmaceutical Product Development | Synarc | |
|---|---|---|---|
| Annual Sales ($ mil.) | 10.6 | 1,414.5 | 102.2 |
| Employees | -- | -- | 600 |
| Market Cap ($ mil.) | 4.9 | 5,050.1 | -- |
Competitive Landscape
